DEKALB REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
DEKALB REGIONAL MEDICAL CENTER is a 97-bed under-performing / distressed in DEKALB, AL with $50.3M in net patient revenue and a -15.9% operating margin. The hospital serves a payer mix of 24.0% Medicare, 21.9% Medicaid, and 54.2% commercial.
Thesis: Turnaround. Our ML models identify $3.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.9% to -8.6% (+736bps).
| Net Revenue HCRIS | $50.3M |
| Current EBITDA COMPUTED | $-8.0M |
| Operating Margin COMPUTED | -15.9% |
| Occupancy HCRIS | 24.9% |
| Revenue / Bed COMPUTED | $518K |
| Net-to-Gross HCRIS | 10.9% |
| Distress Probability ML | 57.1% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -15.9% places it below the state median. Among 32 size-comparable peers (48-194 beds), the median margin is -3.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (48-194), prioritizing same-state peers. 32 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DEKALB REGIONAL MEDICAL CENTER (Target) | AL | 97 | $50.3M | -15.9% |
| CRESTWOOD MEDICAL CENTER | AL | 164 | $258.9M | 14.6% |
| THOMAS HOSPITAL | AL | 164 | $244.7M | 6.2% |
| FLOWERS HOSPITAL | AL | 193 | $235.5M | 14.2% |
| SPRINGHILL MEMORIAL HOSPITAL | AL | 179 | $216.2M | -3.8% |
| MARSHALL MEDICAL CENTERS SOUTH | AL | 178 | $186.9M | -6.3% |
| SOUTH BALDWIN REGIONAL MEDICAL | AL | 112 | $168.2M | 46.4% |
| CULLMAN REGIONAL | AL | 137 | $167.1M | -4.9% |
| HELEN KELLER HOSPITAL | AL | 178 | $92.0M | -28.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $996K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $612K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $32K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-8.0M |
| + RCM Uplift | +$3.7M |
| Pro Forma EBITDA | $-4.3M |
| Current Margin | -15.9% |
| Pro Forma Margin | -8.6% |
| WC Released (1x) | $1.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-12.3M | $-15.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-12.3M | $-21.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-11.1M | $-13.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-11.1M | $-17.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-13.5M | $-30.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-13.5M | $-37.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 24.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 57.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 32 hospitals with 48-194 beds
- Same-state prioritization (n=33)
- Comp margins: P25=-15.2% / P50=-3.8% / P75=12.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.